The global insulin pens market is poised for substantial growth, with its valuation expected to rise from USD 35 billion in 2023 to USD 66 billion by 2033, driven by a compound annual growth rate (CAGR) of 6.5%. This growth reflects increasing global diabetes prevalence and a shift towards more convenient and efficient diabetes management …
Continue reading “Insulin Pens Industry to Reach USD 66 Billion by 2033, Growing at a 6.5% CAGR”